Cliramitug lowers cardiac amyloid burden in long-term ATTR-CM follow-up
Long-term NI006-101 follow-up found cliramitug remained safe and drove further amyloid depletion, biomarker improvement, and cardiac remodeling in ATTR-CM.
By Dr. Aishwarya N., MBBS
·
Oct 20, 2026
·
5 min read